Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    September 2023
  1. LOU Y, Jiang S, Song M, Wang H, et al
    Epithelial TIPE1 Protein Guards against Colitis by Inhibiting TNF-alpha-Mediated Inflammation.
    J Immunol. 2023;211:874-884.
    PubMed     Abstract available

    June 2023
  2. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    PubMed     Abstract available

    January 2023
  3. CARDINALE CJ, Abrams DJ, Mentch FD, Cardinale JA, et al
    Elevated Levels of the Cytokine LIGHT in Pediatric Crohn's Disease.
    J Immunol. 2023 Jan 23:ji2200652. doi: 10.4049/jimmunol.2200652.
    PubMed     Abstract available

    July 2022
  4. MANOHARAN I, Swafford D, Shanmugam A, Patel N, et al
    Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota.
    J Immunol. 2022;209:368-378.
    PubMed     Abstract available

    November 2021
  5. ALI H, Dong SXM, Gajanayaka N, Cassol E, et al
    Selective Induction of Cell Death in Human M1 Macrophages by Smac Mimetics Is Mediated by cIAP-2 and RIPK-1/3 through the Activation of mTORC.
    J Immunol. 2021;207:2359-2373.
    PubMed     Abstract available

    October 2021
  6. BHAUMIK S, Mickael ME, Moran M, Spell M, et al
    RORgammat Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    J Immunol. 2021;207:2027-2038.
    PubMed     Abstract available

    September 2021
  7. KEIR ME, Fuh F, Ichikawa R, Acres M, et al
    Regulation and Role of alphaE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease.
    J Immunol. 2021 Sep 24. pii: jimmunol.2100220. doi: 10.4049/jimmunol.2100220.
    PubMed     Abstract available

    March 2021
  8. XU N, Bai X, Liu Y, Yang Y, et al
    The Anti-Inflammatory Immune Response in Early Trichinella spiralis Intestinal Infection Depends on Serine Protease Inhibitor-Mediated Alternative Activation of Macrophages.
    J Immunol. 2021;206:963-977.
    PubMed     Abstract available

    January 2021
  9. KUMAR R, Singh AK, Starokadomskyy P, Luo W, et al
    Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis.
    J Immunol. 2021 Jan 27. pii: jimmunol.2000015. doi: 10.4049/jimmunol.2000015.
    PubMed     Abstract available

    December 2020
  10. MORGAN NN, Mannon PJ
    Flagellin-Specific CD4 Cytokine Production in Crohn Disease and Controls Is Limited to a Small Subset of Antigen-Induced CD40L(+) T Cells.
    J Immunol. 2020 Dec 9. pii: jimmunol.2000918. doi: 10.4049/jimmunol.2000918.
    PubMed     Abstract available

  11. FAY NC, Muthusamy BP, Nyugen LP, Desai RC, et al
    A Novel Fusion of IL-10 Engineered to Traffic across Intestinal Epithelium to Treat Colitis.
    J Immunol. 2020;205:3191-3204.
    PubMed     Abstract available

    November 2020
  12. WEHRLI M, Schneider C, Cortinas-Elizondo F, Verschoor D, et al
    IgA Triggers Cell Death of Neutrophils When Primed by Inflammatory Mediators.
    J Immunol. 2020;205:2640-2648.
    PubMed     Abstract available

    September 2020
  13. HEDL M, Sun R, Abraham C
    Disease Risk-Associated Genetic Variants in STAT1 and STAT4 Function in a Complementary Manner to Increase Pattern-Recognition Receptor-Induced Outcomes in Human Macrophages.
    J Immunol. 2020;205:1406-1418.
    PubMed     Abstract available

    July 2020
  14. VARMA M, Kadoki M, Lefkovith A, Conway KL, et al
    Cell Type- and Stimulation-Dependent Transcriptional Programs Regulated by Atg16L1 and Its Crohn's Disease Risk Variant T300A.
    J Immunol. 2020;205:414-424.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.